Adipo Therapeutic
Keith Johns is a seasoned professional with over three decades of experience in business and leadership, particularly within the pharmaceutical sector. Currently serving as Chief Operating Officer at Adipo Therapeutics and a Board Member at Allurion Technologies, Johns is focused on innovative solutions for obesity and diabetes. His previous role as Senior Vice President at Eli Lilly and Company involved global marketing and alliance management in diabetes and obesity, where Keith led significant initiatives for product planning and commercialization. Additionally, Johns founded KJ Consulting, LLC to aid businesses in achieving their growth potential through expertise in brand strategy and market insights. An educational background includes an MBA from UNC Kenan-Flagler Business School and advanced degrees in Hydrogeology.
This person is not in any teams
This person is not in any offices
Adipo Therapeutic
1 followers
Adipo Therapeutic is a biotechnology company that develops polymer-based nanotherapeutics. Its nanotherapeutics utilizes adipocyte browning technique to convert energy-storing bad fat cells into energy-burning good fat cells to transform the treatment of obesity and type 2 diabetes, enabling patients to lose bodyweight naturally and restoringmetabolic balance for millions of people living with diabetes.